343 related articles for article (PubMed ID: 19143838)
21. Crystal structure of the cysteine protease inhibitor 2 from Entamoeba histolytica: functional convergence of a common protein fold.
Casados-Vázquez LE; Lara-González S; Brieba LG
Gene; 2011 Jan; 471(1-2):45-52. PubMed ID: 20951777
[TBL] [Abstract][Full Text] [Related]
22. S1 subsite specificity of a recombinant cysteine proteinase, CPB, of Leishmania mexicana compared with cruzain, human cathepsin L and papain using substrates containing non-natural basic amino acids.
Alves LC; Melo RL; Sanderson SJ; Mottram JC; Coombs GH; Caliendo G; Santagada V; Juliano L; Juliano MA
Eur J Biochem; 2001 Mar; 268(5):1206-12. PubMed ID: 11231271
[TBL] [Abstract][Full Text] [Related]
23. A recombinant form of chagasin from Trypanosoma cruzi: inhibitory activity on insect cysteine proteinases.
Dos Santos Monteiro AC; de Oliveira Neto OB; Del Sarto RP; de Magalhães MT; Lima JN; Lacerda AF; Oliveira RS; Scharfstein J; da Silva MC; Valencia JW; Jiménez AV; Grossi-de-Sa MF
Pest Manag Sci; 2008 Jul; 64(7):755-60. PubMed ID: 18318460
[TBL] [Abstract][Full Text] [Related]
24. Structural and functional aspects of papain-like cysteine proteinases and their protein inhibitors.
Turk B; Turk V; Turk D
Biol Chem; 1997; 378(3-4):141-50. PubMed ID: 9165064
[TBL] [Abstract][Full Text] [Related]
25. Role of the single cysteine residue, Cys 3, of human and bovine cystatin B (stefin B) in the inhibition of cysteine proteinases.
Pol E; Björk I
Protein Sci; 2001 Sep; 10(9):1729-38. PubMed ID: 11514663
[TBL] [Abstract][Full Text] [Related]
26. Crystal structures of reversible ketone-Based inhibitors of the cysteine protease cruzain.
Huang L; Brinen LS; Ellman JA
Bioorg Med Chem; 2003 Jan; 11(1):21-9. PubMed ID: 12467703
[TBL] [Abstract][Full Text] [Related]
27. Identification of EhICP1, a chagasin-like cysteine protease inhibitor of Entamoeba histolytica.
Riekenberg S; Witjes B; Sarić M; Bruchhaus I; Scholze H
FEBS Lett; 2005 Mar; 579(7):1573-8. PubMed ID: 15757643
[TBL] [Abstract][Full Text] [Related]
28. Profiling selectivity of chagasin mutants towards cysteine proteases cruzain or cathepsin L through molecular dynamics simulations.
Toman NP; Kamenik AS; Santos LH; Hofer F; Liedl KR; Ferreira RS
J Biomol Struct Dyn; 2021 Oct; 39(16):5940-5952. PubMed ID: 32715978
[TBL] [Abstract][Full Text] [Related]
29. Structural basis of the unusual stability and substrate specificity of ervatamin C, a plant cysteine protease from Ervatamia coronaria.
Thakurta PG; Biswas S; Chakrabarti C; Sundd M; Jagannadham MV; Dattagupta JK
Biochemistry; 2004 Feb; 43(6):1532-40. PubMed ID: 14769029
[TBL] [Abstract][Full Text] [Related]
30. Importance of the second binding loop and the C-terminal end of cystatin B (stefin B) for inhibition of cysteine proteinases.
Pol E; Björk I
Biochemistry; 1999 Aug; 38(32):10519-26. PubMed ID: 10441148
[TBL] [Abstract][Full Text] [Related]
31. Binding modes of a new epoxysuccinyl-peptide inhibitor of cysteine proteases. Where and how do cysteine proteases express their selectivity?
Czaplewski C; Grzonka Z; Jaskólski M; Kasprzykowski F; Kozak M; Politowska E; Ciarkowski J
Biochim Biophys Acta; 1999 May; 1431(2):290-305. PubMed ID: 10350606
[TBL] [Abstract][Full Text] [Related]
32. The major cysteine proteinase of Trypanosoma cruzi: a valid target for chemotherapy of Chagas disease.
Jose Cazzulo J; Stoka V; Turk V
Curr Pharm Des; 2001 Aug; 7(12):1143-56. PubMed ID: 11472258
[TBL] [Abstract][Full Text] [Related]
33. Recombinant pro-regions from papain and papaya proteinase IV-are selective high affinity inhibitors of the mature papaya enzymes.
Taylor MA; Baker KC; Briggs GS; Connerton IF; Cummings NJ; Pratt KA; Revell DF; Freedman RB; Goodenough PW
Protein Eng; 1995 Jan; 8(1):59-62. PubMed ID: 7770454
[TBL] [Abstract][Full Text] [Related]
34. A comparison of the enzymatic properties of the major cysteine proteinases from Trypanosoma congolense and Trypanosoma cruzi.
Chagas JR; Authie E; Serveau C; Lalmanach G; Juliano L; Gauthier F
Mol Biochem Parasitol; 1997 Sep; 88(1-2):85-94. PubMed ID: 9274870
[TBL] [Abstract][Full Text] [Related]
35. Characterization by spectroscopic, kinetic and equilibrium methods of the interaction between recombinant human cystatin A (stefin A) and cysteine proteinases.
Pol E; Olsson SL; Estrada S; Prasthofer TW; Björk I
Biochem J; 1995 Oct; 311 ( Pt 1)(Pt 1):275-82. PubMed ID: 7575465
[TBL] [Abstract][Full Text] [Related]
36. The propeptide of cruzipain--a potent selective inhibitor of the trypanosomal enzymes cruzipain and brucipain, and of the human enzyme cathepsin F.
Reis FC; Costa TF; Sulea T; Mezzetti A; Scharfstein J; Brömme D; Ménard R; Lima AP
FEBS J; 2007 Mar; 274(5):1224-34. PubMed ID: 17298440
[TBL] [Abstract][Full Text] [Related]
37. Dissecting a novel allosteric mechanism of cruzain: A computer-aided approach.
Hernández Alvarez L; Barreto Gomes DE; Hernández González JE; Pascutti PG
PLoS One; 2019; 14(1):e0211227. PubMed ID: 30682119
[TBL] [Abstract][Full Text] [Related]
38. Roles of naturally occurring protease inhibitors in the modulation of host cell signaling and cellular invasion by Trypanosoma cruzi.
Scharfstein J; Lima AP
Subcell Biochem; 2008; 47():140-54. PubMed ID: 18512348
[TBL] [Abstract][Full Text] [Related]
39. Inhibition mechanism of cathepsin L-specific inhibitors based on the crystal structure of papain-CLIK148 complex.
Tsuge H; Nishimura T; Tada Y; Asao T; Turk D; Turk V; Katunuma N
Biochem Biophys Res Commun; 1999 Dec; 266(2):411-6. PubMed ID: 10600517
[TBL] [Abstract][Full Text] [Related]
40. Altered expression of cruzipain and a cathepsin B-like target in a Trypanosoma cruzi cell line displaying resistance to synthetic inhibitors of cysteine-proteinases.
Yong V; Schmitz V; Vannier-Santos MA; de Lima AP; Lalmanach G; Juliano L; Gauthier F; Scharfstein J
Mol Biochem Parasitol; 2000 Jun; 109(1):47-59. PubMed ID: 10924756
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
